Pages that link to "Q42212809"
Jump to navigation
Jump to search
The following pages link to Comparative efficacy and safety of oral mexiletine and quinidine in benign or potentially lethal ventricular arrhythmias (Q42212809):
Displaying 14 items.
- Effects of hyperkalaemia on the depression of maximum rate of depolarization by class I antiarrhythmic agents in guinea-pig myocardium (Q35870956) (← links)
- Electrophysiological effects of the combination of mexiletine and flecainide in guinea-pig ventricular fibres (Q35872072) (← links)
- A treatment algorithm for neuropathic pain (Q35874148) (← links)
- Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges ahead (Q36289359) (← links)
- Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs (Q36462079) (← links)
- Cardiac repolarisation and drug regulation: assessing cardiac safety 10 years after the CPMP guidance (Q37012882) (← links)
- Mexiletine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in the treatment of arrhythmias (Q37977364) (← links)
- Prognostic factors affecting diagnosis and treatment of congestive heart failure (Q38730614) (← links)
- Oscillations of cardiac wave length and proarrhythmia (Q39661961) (← links)
- Assessment of proarrhythmic activity of chloroquine in in vivo and ex vivo rabbit models (Q41347041) (← links)
- Mexiletine inhibits nonadrenergic noncholinergic lower oesophageal sphincter relaxation in rabbits (Q44371429) (← links)
- Class I antiarrhythmics inhibit Na absorption and Cl- secretion in rabbit descending colon epithelium (Q46597255) (← links)
- Chronic mexiletine therapy for suppression of ventricular arrhythmias. (Q54127291) (← links)
- Characterisation of mexiletine's translational therapeutic index for suppression of ischaemia-induced ventricular fibrillation in the rat isolated heart (Q95323110) (← links)